VAERS reports by lot

Moderna COVID-19 lot 046821A: VAERS reports

31 VAERS reports list lot 046821A as a Moderna COVID-19 vaccine, received between 2021-03-25 and 2023-01-02. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
31
Reports
16%
Marked serious
2
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2824%
Neurological1916%
Musculoskeletal1412%
Gastrointestinal1311%
Cardiac / Cardiovascular119%
Dermatological (non-injection-site)87%
Injection-site / Local reaction87%
Allergic / Anaphylactic76%
Respiratory43%
Thrombotic / Hematological33%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 10).

Florida8
Virginia5
California4
Texas3
Pennsylvania3
New York2
Wisconsin1
Georgia1
Maryland1
Kentucky1

Reports by month received

2021-031
2021-049
2021-053
2021-074
2021-084
2021-105
2021-113
2022-021
2023-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.